Papers/PMID:41091332
The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
Clinical drug investigation2025The record
1 finding drawn from this paper, on 1 compound across 1 endpoint.
What it reported
How to read these marksWhat moved
1 finding
Bacopa monnieri — increases adverse event occurrence (oral or enteral supplement)
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Finding“Bacopa monnieri supplementation was generally well-tolerated, with no serious adverse reactions, although there was a greater frequency of self-reported adverse reactions in the Bacopa monnieri group (p = 0.024), primarily comprising digestive complaints and headaches.”
Quoted verbatim from The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.. - Study
- RCT
- Duration
- 3 months
- Dose
- 300 mg daily
- Population
- Adults aged 40-70 years with self-reported memory and attention problems